Eliminating device tax could boost R&D investment in diabetes therapy

04/2/2014 | Hill, The

Diabetes treatment has substantially improved in recent years, thanks to the development of glucose monitors, patch pumps and other innovative devices, writes Consumers' Research Executive Director Joe Colangelo. These advances, however, are being stifled by the medical device tax. "Reducing or eliminating the medical device tax ... will increase the money that diabetes-focused companies are able to invest into future research," he writes.

View Full Article in:

Hill, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC